The deal will require the approval of Thakral Corp shareholders at an EGM to be called.
Thakral Corporation plans to pay $93.9 million to increase its stake in a real estate and healthcare project in India from 13.64% to 95.28%.
This additional 81.64% stake will be bought from a subsidiary of Thakral Group, an entity that is controlled by the extended Thakral family, and which is also the controlling shareholder of Thakral Corp itself.
